Navigation Links
Uroplasty Reports Third Quarter Fiscal 2009 Results
Date:2/3/2009

4,687 (2,769) Share-based consulting expense 52,567 37,942 Share-based compensation expense 583,013 829,146 Deferred income taxes (11,531) 7,113 Deferred rent (26,250) (26,250) Changes in operating assets and liabilities: Accounts receivable 668,510 (534,542) Inventories (34,427) 64,390 Other current assets and income tax receivable 8,173 191,921 Accounts payable (91,686) 94,198 Accrued liabilities (802,027) 312,158 Accrued pension liability, net (7,585) (247,388) Net cash used in operating activities (668,157) (1,603,028) Cash flows from investing activities: Proceeds from sale of short-term investments 14,157,410 4,200,000 Purchase of short-term investments (7,891,373) (3,648,447) Purchases of property, plant and equipment (181,354) (210,875) Proceeds from sale of equipment - 4,811 Payments for intangible assets (23,282) (92,013) Net cash provided by investing activities 6,061,401 253,476 Cash flows from financing activities: Proceeds from financing obligations - 178,374 Repayment of debt obligations (455,913) (239,872) Net proceeds from issuance of common stock, warrants and option exercise - 5,374,233 Net cash provided by (used in) financing activities (455,913) 5,312,735 Effect of exchange rates
'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Uroplasty to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York
2. Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31, 2007
3. Uroplasty to Host Third Quarter Conference Call on February 11
4. Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
5. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
6. Recent Reports Regarding Mercury and High Fructose Corn Syrup Flawed and Misleading
7. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
8. Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
9. CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009
10. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
11. Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - RepliCel Life ... stage regenerative medicine company, is pleased to announce that ... injector (RCI-02) have been locked.  Prototypes for industrial ... prepare for an application for CE mark clearance ... in 2016. (Photo: ...
(Date:7/29/2015)... ... July 29, 2015 , ... CSSi LifeSciences™ formalized ... specializing in Clinical Trial Management. CSSi LifeSciences is specialized in strategic, marketing, and ... PRC Clinical is focused on Clinical Trial Management, Clinical Site Monitoring, and Clinical ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... (BI) advanced cell culture products, announces the availability of BI’s line of human ... Biological Industries, these stem cell differentiation media offer a complete system for multipotency ...
Breaking Biology Technology:Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3
... NORCROSS, Ga., Aug. 18 Immucor, Inc. (Nasdaq: ... the blood transfusion industry, today announced that its board of directors ... its current stock repurchase program. , , ... million shares available for repurchase. To date in its first fiscal ...
... NEW YORK, Aug. 18 /PRNewswire-Asia-FirstCall/ ... ("the Company" or "AOBO"), a pharmaceutical,company dedicated to improving ... range of prescription and over the counter ("OTC"),products in ... Jinji,Capsules and Boke Nasal Spray, were awarded the designation ...
... ISELIN, N.J., Aug. 18 SyntheMed, Inc. ... the development and commercialization of anti-adhesion products, announced today ... the reduction of adhesions following cardiac surgery, has received ... Federation for use in all patients who undergo open ...
Cached Biology Technology:Immucor Announces 2 Million Share Increase to Stock Repurchase Program 2American Oriental Bioengineering's 'Jinji Capsules' and 'Boke Nasal Spray' Designated Among 'China's Top Branded Drugs of 2009' 2American Oriental Bioengineering's 'Jinji Capsules' and 'Boke Nasal Spray' Designated Among 'China's Top Branded Drugs of 2009' 3SyntheMed Receives Russian Regulatory Approval for REPEL-CV(TM) 2
(Date:6/24/2015)... Calif. , June 24, 2015  Synaptics ... of human interface solutions, today announced that Sharp ... to provide secure authentication for its latest flagship ... reached more than 200 million shipments of its ... Sharp reinforces Synaptics, strength, scalability and leadership in ...
(Date:6/24/2015)... 2015 Biometry authentication provider KeyLemon today ... solution one face in. Logo ... face in, entering the expanding biometric authentication market ... biometric answer to the password problem. With advanced ... with KeyLemon, one face in allows users to ...
(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... especially if they,ve been sneaking The highly ... breeding behavior, where non-parents contribute to rearing the offspring ... assumed that male subordinates never gained paternity in the ... online journal PLoS ONE , reveals that some ...
... electoral victory or defeat is influenced by his or ... Stanford University studies of the most recent presidential and ... looking at whether candidates, statements on climate change translated ... and of political science at Stanford, who led two ...
... scientists have received National Science Foundation (NSF) funding to ... understand the behavior of entire ecosystems, part of the ... climate and land-use change. Professor William McDowell ... (NREN) and assistant professor Wilfred Wollheim of NREN and ...
Cached Biology News:Stanford researchers examine impact of 'green politics' on recent national elections 2Stanford researchers examine impact of 'green politics' on recent national elections 3UNH researchers receive NSF grant to 'scale up' stream ecology 2UNH researchers receive NSF grant to 'scale up' stream ecology 3
Anti-Tissue Trans-glutaminase (IgA) EIA Sample Size: 10 l...
... Bullseye Red Taq DNA Polymerase is ... very high activity in primer extension and ... a red dye which provides easy and ... was added and allows confirmation of complete ...
... Kit (E-22013) provides,researchers with a sensitive ... in solution. This fluorescence-based assay can ... (Figure 1). The assay,measures lysozyme activity ... labeled to such a degree that ...
RNA oligomers from 10 to 50 bases purified by PAGE and MS-checked. RNAs are supplied dried and fully deprotected....
Biology Products: